Posted by Michael Wonder on 08 Feb 2018
Subsidy for HIV prevention drug PrEP to slash cost from 10,000 dollars a year to just 474 dollars
8 February 2018 - Drug that reduces risk of infection expected to be added to Pharmaceutical Benefits Scheme.
An incredibly effective HIV prevention drug looks likely to be approved for federal subsidy this week, slashing the price from close to $10,000 a year to only $474.
The federal health minister, Greg Hunt, has promised that PrEP (Pre-exposure prophylaxis) – a daily preventative drug that reduces the risk of HIV infection by up to 99% – will be added to Australia’s Pharmaceutical Benefits Scheme (PBS) if the Pharmaceutical Benefits Advisory Committee recommends it.
